The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
In-Sun Oh, BA
Advertisement
Articles by In-Sun Oh, BA
Advertisement
Latest Updated Articles
- Prescribing Trend of Pioglitazone After Safety Warning Release in Korea
November 19th 2019
Advertisement
Advertisement
Trending on AJMC
1
FAQs: FDA Lawsuit Challenges E-Cigarette Enforcement Policy, PMTA Guidance
2
Medicaid MFN Pricing Could Save $8.6 Billion
3
Active US Drug Shortages Rise for Third Straight Quarter
4
Cognitive Rehabilitation Improves Functional Outcomes in Long COVID Brain Fog
5